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Abstract
The study of epithelial morphogenesis is fundamental to increasing our understanding of organ function and disease. Great
progress has been made through study of culture systems such as Madin-Darby canine kidney (MDCK) cells, but many
aspects of even simple morphogenesis remain unclear. For example, are specific cell actions tightly coupled to the
characteristics of the cell’s environment or are they more often cell state dependent? How does the single lumen, single cell
layer cyst consistently emerge from a variety of cell actions? To improve insight, we instantiated in silico analogues that
used hypothesized cell behavior mechanisms to mimic MDCK cystogenesis. We tested them through in vitro
experimentation and quantitative validation. We observed novel growth patterns, including a cell behavior shift that
began around day five of growth. We created agent-oriented analogues that used the cellular Potts model along with an
Iterative Refinement protocol. Following several refinements, we achieved a degree of validation for two separate
mechanisms. Both survived falsification and achieved prespecified measures of similarity to cell culture properties. In silico
components and mechanisms mapped to in vitro counterparts. In silico, the axis of cell division significantly affects lumen
number without changing cell number or cyst size. Reducing the amount of in silico luminal cell death had limited effect on
cystogenesis. Simulations provide an observable theory for cystogenesis based on hypothesized, cell-level operating
principles.
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Introduction
Epithelial morphogenesis is fundamental to the development and
functional specialization of tissues and organs. Tight regulation of
tissue size, shape and polarization is critical for normal organ
development and function. Disruption of these regulatory mecha-
nisms leads to an array of diseases including autosomal dominant
polycystic kidney disease, stenosis, and cancer. Epithelial cells, such
as Madin-Darby canine kidney (MDCK) cells, cultured in a 3D
matrix of natural basement membrane components, can recapitu-
late in vitro many of the in vivo growth characteristics of epithelial
organs. They are thus valuable model systems for studying the
cellular mechanisms of in vivo epithelial morphogenesis. Their
phenotypic simplicity coupled with accumulated knowledge of their
molecular biology provide excellent case studies for gleaningneeded
insight into how molecular events and environmental feedback
pathways at subcellular levels lead to cell- and cyst-level phenotype.
These model systems lend themselves to computational analysis and
modeling as the means to gain that insight and improve our
understanding of organogenesis.
To achieve that goal, we must first develop explanatory and
easily challenged computational, mechanistic models. In biological
research, explanatory mechanistic models generally precede
predictive mechanistic models. The operating principles of expla-
natory mechanistic models of the type described herein are
hypotheses about how we think phenomena are generated. The
models are part of frameworks for generating and testing
mechanistic hypotheses, as described in [1,2].
While many aspects of MDCK cyst formation are well
understood, quantitative data for cystogenesis has been lacking.
The most recent computational models [1-4] relied on previously
published quantitative data that described a few aspects of MDCK
cyst growth in collagen cultures [5]. There is limited data available
on the dynamics of cell number, cyst and lumen size, and mean
cell size in Matrigel cultures. That caused previous models to
assume that cell size remains constant. The presented data
demonstrate that cell size varies during the course of cyst growth.
An objective of the project was to couple in vitro and in silico
model systems to achieve a deeper understanding of cell behavior
during MDCK cystogenesis within 3D Matrigel cultures. Of
specific interest were the roles played by, and the timing of
polarization, apoptosis, and lumen expansion. In order to improve
our understanding of the link between individual cell behavior and
cystogenesis, we proceeded in parallel on two fronts. We
undertook new in vitro experiments designed to provide a more
temporally and spatially fine-grained record of cell-level events
during the first ten days of MDCK cystogenesis. These
experiments and their results are described in this report. A
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stage of cyst growth after cyst initiation and lumen creation and
expansion. That stage was characterized by the presence of a new
cell state marked by a decrease in cell division rate and cessation of
the decrease in cell size observed in previous stages. We refer to a
cell in that state as being ‘‘stabilized’’.
We also developed and iteratively refined abstract, spatially fine-
grained, multi-attribute, mechanistic, in silico, MDCK cell
analogues (ISMAs) capable of cystogenesis. To create and validate
ISMAs, we merged two modeling techniques while introducing
several novel features. Following rounds of iterative mechanism
refinement (including falsification and validation), time-dependent
measuresofseveralinsilico cystogenesisphenomena,includingsizes
of cells, cysts, and lumens, cell number, and lumen number, became
quantitatively indistinguishable from corresponding in vitro mea-
sures. The process led to two successful ISMAs that had similar
operating principles but relied on different mechanistic hypotheses
for how cells stabilized. In one, cells relied on information about the
lumen. In the other, transition to the stabilized state was a simple
timed event. Independent in vitro experiments [6], which used
molecular interventions to alter the axis of cell division in two
different ways, provided data that challenged ISMA mechanisms
and the predictions of the cystogenic consequences of such
interventions. ISMA mechanisms survived the falsification chal-
lenge: measures of cystogenesis during simulation experiments
mimicking both interventions were quantitatively similar to in vitro
data. This further supported our hypothesis that the cause-and-
effect relationships (mechanisms) occurring within ISMAs during in
silicocystogenesis(and thustheirmorphogenicagenda) haveinvitro
counterparts, both in the presence and absence of mechanistic
interventions. By challenging these in silico mechanisms we better
understand their in vitro cellular counterparts.
Results
Quantitative in vitro results
In order to study the process of cyst development in detail,
MDCK cells were grown and observed in 3D Matrigel culture for
one to ten days and analyzed quantitatively each day. As shown in
Figure 1, cysts developed in a manner consistent with previous
observations [7-9]. A suspension of mostly single MDCK cells
divided to form small clusters during the first 24 hours. Most cells
polarized (defined by podocalyxin localization at the nascent
apical surface of the cell) during the first two days of growth and all
cells polarized by day 3. Cysts developed single (11 of 20) or
multiple (9 of 20) lumens by the end of day 2. Most cyst cross-
sections appeared circular. The deviation from a circle ranged
between 2 and 5%.
We measured and recorded cyst and lumen area and perimeter,
cell number, the number of single and multiple lumen cysts, and
the number of single-lumen, single-(cell) layer (SLSL) cysts. Results
are graphed in Figures 2 and 3. We calculated mean cell area and
the ratio of total cellular area to total cyst area.
Cell number increased exponentially through day 5. It slowed
and increased at a constant rate after day 6. Coincident with that
shift, the variance in cell number per cyst increased (Figure 2A).
Cyst and lumen area increased monotonically (Figure 2B). Mean
cell size decreased at a constant rate through day 6 (Figure 2C)
and then leveled off at roughly the same time that cell division
slowed. Mean cell size increased slightly following the shift. Cell
size variance was smallest on days 5–8. We did not find a strong
correlation between mean cell size and other cyst measurements,
including cell number, lumen size, lumen number, or lumen
perimeter/cell number. The ratio of total cellular area to cyst area
Figure 1. In vitro MDCK cyst cross-sections. Culture conditions
were as described in the text. Confocal images were recorded on the
indicated day during cystogenesis. Colors reflect component staining as
follows: red: actin; green: gp135/podocalyxn; yellow: red and green
colocated; blue: nuclein; black: Matrigel. ML: a multi-lumen cyst. The
arrow indicates a second, small lumen. Not SLSL: this single lumen cyst




Epithelial cells perform essential functions throughout the
body, acting as both barrier and transporter and allowing
an organism to survive and thrive in varied environments.
Although the details of many processes that occur within
individual cells are well understood, we still lack a
thorough understanding of how cells coordinate their
behaviors to create complex tissues. In order to achieve
deeper insight, we created a list of targeted attributes and
plausible rules for the growth of multicellular cysts formed
by Madin-Darby canine kidney (MDCK) cells grown in vitro.
We then designed in silico analogues of MDCK cystogen-
esis using object-oriented programming. In silico compo-
nents (such as the cells and lumens) and their behaviors
directly mapped to in vitro components and mechanisms.
We conducted in vitro experiments to generate data that
would validate or falsify the in silico analogues and then
iteratively refined the analogues to mimic that data. Cells
in vitro begin to stabilize at around the fifth day even as
cysts continue to expand. The in silico system mirrored
that behavior and others, achieving new insights. For
example, luminal cell death is not strictly required for
cystogenesis, and cell division orientation is very important
for normal cyst growth.
Mechanisms of MDCK Cystogenesis
PLoS Computational Biology | www.ploscompbiol.org 2 April 2011 | Volume 7 | Issue 4 | e1002030(Figure 2D) indicated that the portion of cyst occupied by cells
decreased as cysts expanded (and thus the portion occupied by
lumen increased). The ratio decreased quite steeply between days
5 and 6 with very little overlap; the majority of cysts at day 5 had a
ratio higher than 0.6 and the majority of cysts at day 6 had a ratio
lower than 0.6. These observations taken together indicated a shift
in cell behavior occurred at approximately day 5 (referred to
hereafter as simply the shift). The data also supports the idea that
cell compression during lumen expansion may be a factor
triggering cell entry into the stabilized state.
Lumen percentages in vitro
During the first day of growth, some cysts developed lumens,
while others had no visible lumen. From days 2-10 all cysts had at
least one lumen (Figure 3A). Multiple lumens appeared in a
number of cysts, but their frequency decreased over time. Previous
studies [6] considered cysts to be ‘‘normal’’ if they contained a
single layer of actin and apical membrane markers surrounding a
single lumen. We distinguished between single-layer, single-lumen
(SLSL) cysts, in which all cells contact both extracellular matrix
and lumen; cysts with a single lumen where some cells did not
touch the extracellular matrix or the lumen; and cysts with
multiple lumens (Figure 1). After day 2, the percentage of SLSL
cysts ranged between 55% and 85% (Figure 3B), in rough
agreement with the 80% of cysts observed by Zheng et al. to be
‘‘normal’’ [6]. In cases where single-lumen cysts did not have a
single layer of cells, usually only one or two cells did not contact
the lumen or extracellular matrix. These data indicate that the
Figure 2. Quantitative measures of in vitro and in silico cystogenesis. Mean values and standard deviations for (A) cell number per cyst,
(B) cyst and lumen area, (C) mean individual cell area and (D) ratio: cellular to cyst area. Blue: in vitro data taken each day for ten days from 20 cysts.
Red: data taken from 50 CYSTS over ten DAYS using the parameter values in Table 2. Gray boxes: noted changes in behavior. Blue lines: slope of in vitro
growth illustrating changes in rate. SSM1: Self -Similarity Measure of in vitro growth; SSM1 indicates the percentage of in vitro values each day that
fell within 625% of the mean in vitro value for that day. SM1: Similarity Measure for ISMA growth. SM1 indicates the percentage of ISMA values each
day that fell within 625% of the mean in vitro value for that day. The target was that SM1.0.5 for nine of ten DAYS. When the target was met, we
posited that ISMA measures were experimentally indistinguishable from in vitro measures. Gray SM values did not achieve targeted values.
doi:10.1371/journal.pcbi.1002030.g002
Figure 3. Percentage of cysts with different numbers of
lumens. (A) Percentage of cysts that have single (solid circle) or
multiple (open circle) lumens. (B) Percentage of SLSL (single-layer,
single-lumen) cysts. Blue: in vitro data for 20 cysts taken each day for
ten days. Red: in silico data for 50 CYSTS using parameters values from
Table 2. Black: mean and standard deviation for ‘‘normal’’ MDCK cysts
observed by Zheng et al. [6] as described in the text. Solid lines
represent continuous growth of ISMA CYSTS. Dotted lines represent
discrete growth of MDCK cysts.
doi:10.1371/journal.pcbi.1002030.g003
Mechanisms of MDCK Cystogenesis
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as smaller lumens merge together into larger. It is possible that a
few cysts might increase their lumen number over time even as
mean lumen number decreased, but that behavior would only be
observed using time-lapse microscopy of individual cysts.
ISMAs capable of cystogenesis
In order to create and validate ISMAs, we used a number of
modeling techniques and approaches, detailed in Methods. To
avoid confusion between in vitro and ISMA components and
mechanisms with similar names, we use SMALL CAPS when referring
to the latter. Following the Iterative Refinement Protocol (IR
Protocol) led to two specifications of CELL behavior that achieved all
targeted attributes in Table 1 and all prespecified Similarity
Measures (SMs; described below). They are the lumen stabilized
ISMA (LS ISMA) and the timed stabilization ISMA (TS ISMA).
There are only three CELL states: UNPOLARIZED, POLARIZED,a n d
stabilized. Both LS and TS ISMAs have a common morphogenic
agenda. Itisaconsequenceoftheiroperatingprinciples,whicharea
networked consequence of CELL state and micromechanisms. The
latter are primarily axiom-dependent, and the axioms, in turn,
depend onparticular localandtemporalconditions. Theaxiomsare
placeholders for even more fine-grained micromechanisms.
The only difference between the LS and TS ISMAs is the
mechanism used by POLARIZED CELLS to shift to the stabilized state.
Within the LS ISMA, POLARIZED CELLS use information about the
LUMEN to decide when to stabilize. Within the TS ISMA, transition
to the stabilized state is a simple timed event (each CELL used its
own internal clock). We did not discover any in vitro observations
that would provide a basis for selecting one micromechanism over
the other.
CELL operating principles require each CELL to have knowledge
of its internal state and immediate environment, including the size
of the neighboring LUMEN (for the LS ISMA). CELL DIVISION is
based on factors other than CELL size. Early in the process, CYST
size can be independent of LUMEN size. The orientation of CELL
DIVISION is extremely important in influencing the formation and
number of LUMENS within a CYST.
We explored alternative mechanistic variations, but failed to
find others of comparable simplicity capable of achieving all
targeted attributes and prespecified SMs. For simplicity we present
and discuss measures from LS ISMA simulations within the text
(Figures 2 and 3) and provide the same simulation measures for TS
ISMAs in Figures S1 and S2. Results from earlier ISMA that were
falsified because they failed to achieve one or more SMs are also
discussed.
Table 1. Targeted attributes and specifications.
1. A: An initial small cluster of 1-4 cells divides and increases in cell number.
S: The ISMA begins with 2-4 CELLS, which DIVIDE after cycleCounter reaches 0.
2. A: All cells polarize by the second day of growth.
S: CELLS change state to POLARIZED after polarCounter reaches zero.
3. A: One or more lumens develop by the second day of growth.
S: CELLS within CYSTS form LUMENS after CELLS POLARIZE.
4. A: A multilayer of cells separates multiple lumens.
S: CELLS only form LUMENS when they and their neighbors do not already contact LUMEN. After a LUMEN has formed, all neighboring CELLS contact a single LUMEN.
5. A: Cells can undergo apoptosis whether or not they contact the extracellular matrix.
S: CELLS DIE with specified probability. That value is larger for CELLS not in contact with MATRIX.
6. A: The increase in cell number over time is similar that shown in Figure 2, leveling off at day 6.
S: When LUMEN size reaches a critical value, a mechanism causes CELLS to stabilize.
7. A: The increase in cyst size over time is similar to that shown in Figure 2.
S: CYST size is a function of CELL area, CELL number, and LUMEN size.
8. A: The increase in lumen size over time is similar to that shown in Figure 2.
S: LUMEN size is a function of CELL number, CYST perimeter, CELL stretch, and TIME.
9. A: Mean cell area decreases over time as shown in Figure 2, and levels off at day 6.
S: CELLS have distinct mechanisms for (effectively) calculating TA before and after stabilization.
10. A: The decrease in the ratio of cellular to cyst area over time is similar to that in Figure 2, decreasing faster during days 2-6.
S: CELL area, LUMEN size, and CYST size must be measurable and if these quantities validate, then so must the ratio of CELLULAR to CYST area.
11. A: The percentage of single-lumen, multiple lumen, and SLSL cysts each day is similar to that in Figure 3.
S: When CELLS lack LUMEN contact, they can create new LUMENS.L UMEN creation occurs at the site of previous CELL DIVISION.L UMENS
can expand and merge. CELLS that have stabilized cannot create a new LUMEN.
12. A: The percentage of cysts with apoptotic cells each day is similar to that observed in [9].
S: CELLS shrink after beginning to DIE. The percentage of CYSTS with DYING CELLS is calculated as in vitro.
13. A: When the orientation of the cell axis of division is disrupted or reversed, the percentage of normal cysts is reduced as observed in [6].
S: CELLS orient their axis of DIVISION toward the center of prior DIVISION or toward the center of the LUMEN. Axis orientation can be randomized and reversed.
MDCK cells and cysts are the referent. The model system is called an in silico MDCK analogue (ISMA). A: a targeted attribute; S: an ISMA specification. All listed attributes
were achieved. The early version of the ISMA achieved TAs 1-4, but was falsified by the quantitative data. The refined ISMA achieved all TAs except 11, which was
achieved by both the LS and the TS ISMAs.
doi:10.1371/journal.pcbi.1002030.t001
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ISMA CYSTS were similar to cysts grown within Matrigel
(Figure 4). CYSTS began with 1-3 CELLS at DAY 0. CELLS POLARIZED
and formed LUMENS within the first two DAYS (Figure 3 and Video
S1). LUMENS and CYSTS expanded at a rate indistinguishable from
that observed in vitro. In general, a cyst formed with a single
LUMEN surrounded by a single layer of POLARIZED CELLS (Figure 4
and Video S1). Occasionally multiple LUMENS formed, each
separated by an independent layer of CELLS, such that no CELL
contacted more than one LUMEN (Figure 4 and Video S2). The
ISMA successfully achieved all qualitative and quantitative
targeted attributes listed in Table 1.
ISMA CELL number also exhibited two growth phases, with the
rate of CELL DIVISION decreasing at day 6 (Figure 2). LUMEN and
CYST size increased at rates similar to those observed in vitro, but
standard deviations were smaller. CELL size also decreased at a rate
comparable to in vitro, and its standard deviations were also
smaller. As indicated by the values of Similarity Measure 1
(discussed below) in Figures 1 and 2, ISMAs produced quantita-
tive results similar to in vitro values. ISMAs were executed using
the parameter settings in Table 2, and CYST and LUMEN area were
scaled by 2.25 mm
2 and perimeter by 0.75 mm.
Lumen percentages in silico
Simulations produced single and multiple LUMEN CYSTS at
frequencies comparable to those observed in vitro (Figure 3A),
though the percentage of CYSTS with single LUMENS was slightly
higher than observed in vitro. The percentage of SLSL CYSTS
(Figure 3B) leveled off between days 2 and 6 and then increased
steadily to day 10 as LUMENS merged. CELLS that stabilized were
not allowed to create new LUMENS, but could contribute to LUMEN
expansion. If this restriction were to be removed and CELLS were
allowed to create new LUMENS after they stabilized, the percentage
of SLSL CYSTS might remain steady or decrease.
Similarity measures
To provide a validation target for ISMA CYSTOGENESIS and to
compare ISMA and in vitro results, we developed SMs [10], which
quantified the similarity within and between the in silico and in
vitro data. We posit that, if in silico data satisfies the SMs, then
that data would be indistinguishable from data produced by a
repeated in vitro experiment.
SM1 compared results from individual simulations to in vitro
mean values, indicating the similarity of in silico and in vitro
results. SM1 is the percentage of in silico observations that fell
within625% of the mean in vitro value for a given measure. SM1
values are listed in Figure 2. To survive falsification, .50% of
simulations must achieve the SM1 target for nine of ten DAYS,a s
detailed in Methods. For example, the 625% range for in vitro
cell number at day 3 was 6.7 to 11.1 with a mean of 8.9. Seventy-
two percent of simulations had CELL numbers within that range at
DAY 3. SM1 values for CELL number, CYST size, mean CELL area,
and the ratio of CELLULAR to CYST area exceeded 50% at all DAYS,
so a degree of validation was achieved. The SM1 value for LUMEN
size exceeded the 50% cutoff for nine of ten DAYS, although the
values were lower.
To facilitate assessing SM1 values and comparing in vitro and in
silico data, we specified and used Self-Similarity Measure 1
(SSM1). It measured the similarity between the in vitro mean
value and individual in vitro values and thus how closely grouped
around the mean the individual in vitro values were. Similar to
SM1, SSM1 is the percentage of individual in vitro cyst measures
each day that fall within a specified range. SSM1 can be used to
evaluate corresponding SM1 values. Large SSM1 values are a
characteristic of measures having a small variance. Values of
SSM1 were larger than the target for all measures except lumen
size, indicating that lumen size in vitro varied more extensively
about the mean than other quantities.
SM1 did not consider the variance of the data. To address
variance, we specified SM2. It compared the coefficient of
variance of in silico and in vitro experiments. SM2 measured
the absolute value of the difference between the in vitro and in
silico coefficient of variance each DAY. ISMAs survived falsification
if SM2,0.15 for nine of ten DAYS (strong validation) or ,0.25 for
eight of ten DAYS (medium validation). The current ISMA
achieved strong validation for CELL number, mean CELL area,
and the ratio of cellular to cyst area (Table S1). It achieved
medium validation for CYST size and LUMEN size, comparable to
SSM1 values.
Cell death
When MDCK cells can polarize well, they do not need
apoptosis to form cysts with lumens [9]. Consequently, cell death is
relatively uncommon during in vitro MDCK cyst development
[9]: on a given day, no more than 15% of cysts had one or more
apoptotic cells within the lumen and no more than 10% of cysts
had one or more apoptotic cells with matrix contact. CELL DEATH
did occur during ISMA executions, but at slightly lower
frequencies than observed in vitro (Figure 5). In Methods, we
specified that the average duration between a CELL initiating DEATH
and being removed from the simulation to be ten simulation
cycles, which maps to five hours. The actual in vitro duration will
affect the number of visible apoptotic cells observed each day.
Figure 4. In silico MDCK analogue CYST cross sections. Note that a
regular hexagon in hexagonal space maps to a circle in continuous
space. Images are from a single simulation run using parameter settings
from Table 2. CELLS are UNPOLARIZED (green), POLARIZED (gray) or stabilized
(orange). CELL-CELL and CELL-MATRIX borders are red; CELL-LUMEN borders are
yellow; LUMENS are blue. Lower right panel: shown is a multi-LUMEN CYST.
Not SLSL: this single LUMEN CYST does not have a single layer of CELLS. The
arrow indicates two CELLS not in contact with LUMEN.
doi:10.1371/journal.pcbi.1002030.g004
Mechanisms of MDCK Cystogenesis
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values in Figure 5B increased. The experimental results provided
in Figure S3 demonstrate that decreasing the value of dyingShrink-
Rate from 9 to 4.5 increased the mean duration of CELL DEATH
(from 4.6 to 7.4 hours) and increased the percentage of DYING
CELLS. It is noteworthy that all validation targets were achieved
without requiring stabilized CELLS to DIE more frequently than
POLARIZED CELLS. Based on current knowledge, the ISMA
accurately mimics in vitro quantitative data, but the duration of
apoptosis within MDCK cells in vitro has not been quantitatively
established. In order to be certain about the role played by cell
death, time-lapse movies using a caspase-3-GFP will be required.
Altering CELL DIVISION orientation in silico dramatically alters
CYST morphology
After the ISMAs achieved the above, targeted attributes, Zheng
et al. [6] reported measuring the consequences of disrupting cell
division orientation on MDCK cyst morphology. Knocking down
LGN, which plays a role in spindle orientation during cell division,
caused cell division orientation to become random instead of
aligning with the axis perpendicular to the cellular plane. The
frequency of ‘‘normal’’ cysts decreased from roughly 80% to 20-
30%. We added those observations to our targeted attributes list
and then explored the degree to which CYST morphology following
a comparable ISMA intervention would mimic the in vitro results,
thus surviving the challenge. We altered CELL DIVISION so that all
CELLS divided with a random orientation. The results (Figure 6A)
were similar to those of Zheng et al. The altered ISMA produced
less than 20% SLSL CYSTS and more than 30% multi-LUMEN CYSTS
at DAYS 2 through 9. Additional details are available in Figure S4.
In a second experiment, Zheng et al. targeted LGN to the apical
membrane. So doing rotated the axis of division by 90u, thus
Table 2. Primary ISMA parameters.
Parameter Description Default value Range used
wedgeArea W: target area of UNPOLARIZED CELLS and ideal wedge area for POLARIZED CELLS 82 grid points 30-150
lambdaArea Multiplier controls how quickly CELLS change size to reach
their individual target areas
5 grid points 0.5-20
stableTargetArea Target area of stabilized CELLS 48 grid points 30-150
cellCycle Used to calculate cycleCounter, the number of
simulation cycles before a CELL DIVIDES
70 simulation cycles 20-100
lambdaPerim Multiplier controlling how quickly CELLS change
size to reach their target perimeter
2.5 0.5-10
polarDelay Used to calculate polarCounter, the number of simulation
cycles elapsing before an UNPOLARIZED CELL POLARIZES
42 simulation cycles 0-400
shiftDelay In the TS ISMA, used to calculate shiftCounter, the number of
simulation cycles elapsing before a POLARIZED CELL stabilizes
140,000 simulation cycles 0-300
doublingArea When divided by 2, the minimal area a CELL must have to DIVIDE 41 grid points 20-100
divisionReg How the axis of DIVISION is calculated 1 0, 1, 2, 3
multiplier Used to calculate target perimeter of CELLS 0.6 0-1
lumenGrowthRate Multiplier controlling rate of LUMEN expansion 0.003 0-1
deathRateLumen Likelihood of CELLS to DIE when not touching MATRIX 0.02 0-1
deathRateEpi Likelihood of CELLS to DIE when touching MATRIX 0.0004 0-1
clusterProb Probability initial two CELLS will set cycleCounter to zero at simulation cycle 1 0.8 0-1
lgrSubtract Multiplied by CELL stretch to reduce LUMEN expansion 27 0-300
dyingShrinkRate Amount subtracted from target area of DYING CELLS each simulation cycle 9 grid points 0-100
stableRatio Critical LUMEN size (multiplied by 1000) at which CELLS will stabilize 0.5 grid points 0.1-1
stableCycleDelay (1 – x) = probability a stabilized CELL will decrement cycleCounter 0.85 0-1
Parameters critical to the operation of the ISMA are listed along with descriptions, default value used for simulation, and the range of values explored. To switch
between the LS ISMA and the TS ISMA the values of shiftDelay and stableRatio are changed from 140,000 and 0.5 to 200 and 1000. All units are relational (e.g., grid
points instead of mM, simulation cycles instead of hours).
doi:10.1371/journal.pcbi.1002030.t002
Figure 5. Percentage of cysts with dying cells. (A) In vitro data
reproduced from [9]. (B) ISMA data from 50 CYSTS over ten DAYS. Blue
bars: percentage of cysts observed to have apoptotic cells without
matrix contact. Red bars: percentage of cysts observed to have
apoptotic cells with matrix contact.
doi:10.1371/journal.pcbi.1002030.g005
Mechanisms of MDCK Cystogenesis
PLoS Computational Biology | www.ploscompbiol.org 6 April 2011 | Volume 7 | Issue 4 | e1002030reversing cell division orientation. The procedure reduced the
frequency of normal cysts to roughly 10%. We conducted a similar
experiment by modifying ISMAs so that the axis of DIVISION was
parallel, rather than perpendicular to the LUMEN edge. That
intervention produced SLSL CYSTS less than 10% of the time
(Figures 6B and S5). ISMAs survived both challenges; in both
cases, altering the orientation of CELL DIVISION decreased the
percentage of single LUMEN and SLSL CYSTS to a degree similar to
that observed within in vitro experiments.
In silico CYST growth with no LUMINAL CELL DEATH
Cell death contributes to cystogenesis, but it remains unclear to
what extent it is essential. In order to explore the consequences of
decreased CELL DEATH frequency, we executed simulations in
which we reduced deathRateLumen from 0.02 to 0.0. We did not
alter the probability of CELL DEATH in CELLS contacting MATRIX.W e
noted no significant difference in CELL number during the first six
DAYS of growth, but during days 7 through 10 mean CELL
number was 10-15% higher than observed during control ISMA
growth (Figure 7A). The observed standard deviations also
increased. We observed a smaller percentage of SLSL CYSTS than
in control simulations, especially during DAYS 6 to 10 (Figure 7B).
Values for CYST area, LUMEN area, CELL size, and the ratio of
CELLULAR to CYST area were similar to control values (Figure S6),
while the percentage of single LUMEN CYSTS decreased slightly
(Figure S7).
Simulated CYST growth with delayed CELL POLARIZATION
Delayed cell polarization is believed to contribute to the
differences in cyst growth in Matrigel and collagen [9], although it
is possible that a lower initial rate of cell clustering and a slower
growth rate might be factors as well. To explore the effect of
delayed POLARIZATION on ISMA CYSTOGENESIS, we increased the
value of polarDelay from 42 (equivalent to 21 hours) to 130
(equivalent to 65 hours). Relative to controls, CELL number
increased at an equivalent rate during the first six DAYS, but was
larger during DAYS 7–10 (Figure 8A). CELL POLARIZATION (data not
shown) and LUMEN formation occurred later than in controls
(Figure 8B). The area taken up by CELLS remained roughly
constant, but the delay in LUMEN formation and resulting smaller
LUMENS caused the ratio of CELLULAR area to total CYST area to be
significantly larger than control values during DAYS 2-8 (Figure S8).
Not surprisingly, there were fewer single and multiple LUMEN CYSTS
during the first three DAYS. When LUMEN formation began,
however, it often resulted in multiple LUMENS (.80% for DAYS
4–6); SLSL CYSTS were observed infrequently. As LUMENS
expanded and merged during the later stages of growth, the
frequency of SLSL CYSTS increased. The percentage of DYING
CELLS not contacting the MATRIX was significantly larger at DAYS 4–
10, indicating that many of these CELLS DIED as LUMEN expansion
occurred (data not shown). Some of these in silico results reflect
those observed within growth in collagen, but it seems unlikely that
delayed cell polarization in vitro is solely responsible for those
differences.
Figure 6. Percentage of ISMA CYSTS with varied LUMEN number
when the axis of CELL DIVISION is abnormal. Shown are the
percentages of CYSTS that have single (solid red circles) or multiple
(open red circles) LUMENS when the axis DIVISION is (A) random or (B)
reversed (rotated 90u) along with the percentage of CYSTS that are SLSL
(purple circles) when the axis of CELL DIVISION is (A) random or (B) reversed.
Black (A and B): mean and standard deviation for ‘‘normal’’ MDCK cysts
observed by Zheng et al. [6]. The in vitro control data are shown in
Figure 3.
doi:10.1371/journal.pcbi.1002030.g006
Figure 7. CYSTOGENESIS measures with no LUMINAL CELL DEATH. ISMA
simulations executed with the parameter values from Table 2 except
that LUMINAL CELL DEATH was not allowed. (A) Red: mean values and
standard deviations for CELL number per CYST. Blue: in vitro control data
from Figure 2A. (B) Percentage of SLSL CYSTS.
doi:10.1371/journal.pcbi.1002030.g007
Figure 8. CYSTOGENESIS measures when CELL POLARIZATION was
delayed. ISMA simulations executed with the parameters values from
Table 2 except that CELL POLARIZATION was delayed as described in the text.
Left: mean values and standard deviations for CELL number per CYST (top
panel) and ratio of CELLULAR to CYST area (bottom panel). Right:
Percentage of CYSTS with single, multiple, and SLSL lumens. Designations
and symbols are the same as in Figures 2 and 3.
doi:10.1371/journal.pcbi.1002030.g008
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In vitro observations
Observations reported herein about in vitro MDCK cystogen-
esis are consistent with those made previously [6,9,11]. There is no
evidence of behavioral differences between cells within single and
multiple lumen cysts. We could not establish a causative
connection between the slowing of cell division and the change
in cell size. The evidence indicates that initial lumen expansion is
somewhat isochoric: early lumen expansion is primarily a
consequence of cell shrinkage. After an interval of lumen
expansion and cell shrinkage lasting about six days, cell behavior
changes: cell size stabilizes and cells begin to stretch as the lumen
continues to expand (Figure 1); cell division slows dramatically; the
expanding lumen becomes the primary driver of cyst size; and the
variance in both cell area and cyst size increases.
Iterative process
Iteratively constructed ISMAs quantitatively mimicked a
targeted set of in vitro data and cell behaviors. Measures of
ISMA CYSTOGENESIS matched corresponding measures of MDCK
cystogenesis over ten days (Figures 2, 3, & 5). The pathways and
proteins that play influential roles in cell behavior during MDCK
cystogenesis are objects of active research and are increasingly well
understood. However, knowledge of how specific cell actions and
events are choreographed during cystogenesis is still limited. The
latter knowledge is needed to begin establishing causal linkages
between molecular level events and systemic phenotype.
Previous analogues [2,3] used a simple representation of a cell:
each CELL occupied a single 2D hexagonal grid space. They were
falsified when we added qualitative observations about changes in
cell size and shape to our targeted attributes list (Table 1). To
mimic these newly targeted attributes, we needed CELLS to be more
fine-grained. To generate the current ISMA, we began with an in
silico analogue that had achieved a degree of validation and then
conducted in vitro experiments designed to challenge and possibly
falsify it. We then reengineered the in silico system to reflect,
explore, and challenge new insight provided by the fresh in vitro
data. We engineered new analogues using the cellular Potts model
(CPM), which provided several capabilities, including enabling
CELL size and shape change. To slow the increase in CELL number
after DAY 6, we introduced a stable CELL state.
We envision the above in silico-wet-lab cycle continuing
indefinitely. It is straightforward to explore the consequences of
in silico mechanistic interventions. If these interventions result in
altered system behaviors (predictions), it may suggest new in vitro
experiments designed to test them. Examples include the effect of
delayed polarization on cyst phenotype, the lack of noticeable
changes when cell death is inhibited, and the causal link between
lumen size and cell stabilization. Furthermore, we expect a change
in cell state (cell stabilization at day 6) to be accompanied by
measurable changes in gene expression profiles and biochemical
signaling.
Improved analogue
The ISMA illustrated in Figure 4 achieved all targeted
attributes. It was preceded by two earlier versions. These ISMAs
differed in the mechanism used to initiate CELL stabilization. We
hypothesized that in vitro cells might use knowledge of their
internal geometry to sense their perceived stretch and subsequent-
ly stabilize. One early analogue, the geometrical mechanism
ISMA (GM ISMA), directly tested this hypothesis; each CELL used
measures of its area and geometry to determine when to shift to
the stabilized state. To achieve a degree of validation required the
use of an axiom specifying that stabilized CELLS would be more
likely than POLARIZED CELLS to DIE when not in contact with
MATRIX. This axiom was implemented in order to decrease the
number of CELLS within the LUMEN and thus increase the number
of SLSL CYSTS. The GM ISMA was falsified when targeted SMs
for the percentage of single LUMEN, multiple LUMEN, and SLSL
CYSTS were strengthened to those achieved in Figure 2 (Figures S9
and S10). It was falsified because the time at which CELLS stabilized
was too variable; some CELLS stabilized early, others much later,
resulting in very few SLSL cysts (data not shown).
A second version, called the timed stabilization ISMA (TS
ISMA), used an internal clock to signal CELL stabilization, resulting
in a uniform stabilization time and reducing the variance in CYST
size. The TS ISMA survived falsification (Figure S1), providing
evidence that stabilization time influences SLSL CYST percentages.
The GM ISMA axiom specifying that stabilized CELLS would be
more likely than POLARIZED CELLS to DIE when not in contact with
MATRIX was not needed. The TS ISMA was capable of generating
high percentages of SLSL cysts even without this axiom, and so the
axiom was removed in that and subsequent ISMAs.
Although the TS ISMA survived falsification, we were not
aware of any in vitro evidence suggesting existence of an
equivalent internal clock-based mechanism. If such a mechanism
does exist, it might be molecularly equivalent to that of cell
polarization. Genes that regulate cellular senescence can suppress
the cell cycle, and the sirtuin protein SIRT1 is involved in cellular
senescence [12,13]. It is possible a cell-autonomous timing
mechanism could exist that depends on the regulation of SIRT1
and its downstream targets, as detailed in Supporting Text S1. We
hypothesized that a mechanism that used the geometry of the
LUMEN instead of the geometry of individual CELLS to signal CELL
stabilization might bridge that gap and still produce a low variance
in stabilization times. We developed the lumen stabilized ISMA
(LS ISMA) described within this report to test that hypothesis and
discovered that in addition to surviving falsification (Figure 2) it
generated stabilization variance between the GM and TS ISMAs.
We can surmise a mapping between the LUMEN-based stabilization
mechanism and a functionally equivalent in vitro mechanism in
which apical sensory input to each cell provides it with information
that correlates to lumen size. Current evidence supports the
hypothesis that cells in the cyst wall can sense lumen size. One
mechanism utilizes the tension generated at the luminal mem-
brane by membrane stretching. This tensional information is
transduced by the subapical F-actin network, which acts both as a
scaffold for maintaining luminal integrity, as well as a region for
aggregation of recycling endosomes that regulate the protein and
lipid composition of the apical plasma membrane. Thus,
regulators of this F-actin network can regulate lumen and cyst
size. Potential molecular mechanisms are detailed in Supporting
Text S1.
We should seek additional, in silico mechanisms that are equally
effective in enabling ISMAs to achieve validation targets. Given
phenomena, what hypothetical generators (and measures) might
generate them? Studying an inverse mapping requires multiple,
seemingly plausible hypotheses, which then compete against each
other during simulation experiments as done here. After
falsification and validation using the IR Protocol, those that
survive spawn additional, more refined hypotheses. Having
multiple mechanistic options for realizing the same behaviors
may be biomimetic in that it marginally increases system
robustness. An example of a potential additional in silico
mechanism is one that uses time-dependent dynamic parameters,
which might assist in the exploration of finer-grained, intracellular
molecular behaviors.
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have implicitly dynamic values (such as the time that elapses
between CELL DIVISION events). They change when CELLS change
state. In general, however, all parameters are fixed for the duration
of the simulation. Expanding the set of targeted attributes may
force consideration of time varying parameter values. If, for
example, in vitro data were targeted that demonstrated the build-
up of certain proteins along the plasma membrane, dynamic
variables could be implemented that controlled the amount of the
PROTEIN counterpart within the analogue.
Challenging ISMA predictions
ISMAs had already achieved all targeted attribute when the
work of Zheng et al. [6] was published. Results from their studies
provided an independent challenge to ISMA mechanisms and
their robustness. The simulation results in Figure 6 are a
consequence of two different simulation interventions: making
the CELL axis of DIVISION random (Figure 6A) and reversing the
CELL axis of DIVISION (rotating it 90u)(Figure 6B). These predictions
are fully consistent with the in vitro results of Zheng et al. As
previously stated, they defined a normal cyst as one with actin
staining at the apical cell surfaces surrounding a single lumen.
Included in that definition are our SLSL CYSTS and CYSTS with a
single LUMEN. In Zheng et al., when cell division was randomized,
the percentage of cysts with single lumens at day 4 dropped from
81.9% to 21.5%, a different of 60.4%. In ISMA simulations, when
divisionReg was changed from 1 (ordered DIVISION) to 0 (random
DIVISION) the percentage of CYSTS with a single LUMEN dropped
from 94% to 46%, a difference of 48%, which is quite similar to
the decrease observed in vitro (Figure 6A). As seen in Figure 6B,
when the axis of division was reversed, the percentage of cysts with
a single lumen dropped from 81.9% to 11.5%, a difference of
70.4%. Within the ISMA, when divisionReg was changed from 1 to
3 (reversed division), the percentage of CYSTS with a single LUMEN
dropped from 94% to 14%, a difference of 80%. In addition, the
in silico results provide a prediction of in vitro behavior that could
be challenged through in vitro experimentation. When DIVISION is
reversed within the LS ISMA (Figure S5A) CELL number continues
to increase after day 6, most likely because the numerous small
LUMENS do not reach a sufficient size to cause CELL stabilization. In
strong contrast, when DIVISION is reversed within the TS ISMA
(Figure S11-2) CELL number stops increasing at day 5 and remains
stable thereafter. Future experiments of the type conducted by
Zheng et al. that quantify cytogenesis over longer intervals
would provide evidence supporting one or the other mechanistic
hypothesis.
CELL-level and INTRACELLULAR events
A CELL-level event is one that is visible at the current level of
resolution. An event that maps to an intracellular process (referred
to as INTRACELLULAR) can occur without causing a visible change; it
is below the current level of resolution. Of the events listed in
Table 3, the two marked (*) only exist within the in silico system
and have no specific in vitro counterpart.
Beyond simply modeling cystogenesis, a purpose of this research
has been to instantiate an in silico system in which CELLS, MATRIX,
and LUMEN have in vitro counterparts, and when executed the
ISMA produces a variety of measurable phenomena that
quantitatively mimic MDCK cystogenesis. At the systemic level,
we have excellent cystogenesis similarity over ten days for multiple
measures (Figures 3-5). Further analogue improvement will,
following additional cycles of the IR Protocol, allow INTRACELLU-
LAR events to become concretized and increasingly fine-grained,
thus enabling quantitative in silico-to-in vitro mappings at multiple
levels.
All specified events were necessary and essential for achieving
targeted SMs. For CELL-level events, the mappings are clear: they
are direct and quantifiable. INTRACELLULAR events, axioms, and
protocols are below the current level of resolution. There is no
requirement that a specific INTRACELLULAR event, axiom, or
protocol has a cell-level counterpart. We simply hypothesize that
the set of INTRACELLULAR events, axioms, and protocols—a CELL’S
operating principles—has an in vitro counterpart, as illustrated in
Figure 9. For some INTRACELLULAR events, conceptual mappings
are clear. Examples include CELL initiates DYING, DEATH advances,
and decrement polarCounter. For others, conceptual mappings are
less clear. Examples include decrement shiftCounter (in the TS
ISMA), compute TP, and compute G. The expectation is that, in
moving forward, as axioms are replaced by concrete, interacting
components (see [14] and the future experiments subsection below)
clear mappings will be easier to establish and quantify.
A good example of a project in which INTRACELLULAR events are
incorporated and to some degree mapped back to those in vitro, is
the IBCell model [15,16]. It is a biomechanical model of MCF-
10A cell cystogenesis in which proteins on the outer cell
membrane and the extracellular matrix are specifically simulated.
The IBCell model successfully reproduced some aspects of
cystogenesis, but it remains unclear whether the INTRACELLULAR
details are necessary or could be replaced by coarse-grained
components. The quantitative data used to validate the model
lacked the level of resolution necessary to falsify intracellular
mechanisms.
CELL DEATH and the timing of CELL POLARIZATION
Surprisingly, CYSTS with little or no CELL death can still be well
organized with a single LUMEN. Reducing CELL DEATH rates
Table 3. CELL and INTRACELLULAR events that can occur within a
simulation cycle.
CELL-Level Events Map to Intracellular Events
CELL state (& color) changes MCell point assignment*
CELL DIVISION CellCycle updating at simulation cycle 1
LUMEN creation CELL initiates DYING








LUMEN expansion without TJ
reorganization
Decrement cycleCounter
Isolated point engulfed* Decrement polarCounter
CELL perimeter





Compute MATRIX and LUMEN
contact length, A, TA, & TP
MATRIX removal Compute G for a potential index change
CELLS change shape
*This event exists only within the ISMA system and has no specific cystogenesis
counterpart.
All CELL events produce a visible change within the ISMA visualization. Events
that map to intracellular events result in a change within a CELL, but do not
produce a visible change within the ISMA. CELL-level events map to equivalent
events between in vitro MDCK cells, lumen, and matrix, while INTRACELLULAR
events map to events (less well understood) within in vitro MDCK cells.
doi:10.1371/journal.pcbi.1002030.t003
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because CELL DEATH frequency was already low (Figure 5B). Lin et
al. [17] hypothesized that apoptosis is crucial for lumen formation
in MDCK cysts, but they reached that conclusion based on
observations of cystogenesis in collagen culture only. Martı ´n-
Belmonte et al. [9] observed that apoptosis within Matrigel
cultures is less frequent than within collagen cultures. Within
ISMA simulations, earlier LUMEN formation results in more
organized CYST growth and fewer CELLS that DIE after losing
contact with the MATRIX once LUMENS have formed. It is possible
that apoptosis acts simply as a cleanup mechanism within MDCK
cysts, but the degree to which it is utilized depends on the
environment, the rate of cell growth, and the timing of
polarization. Our experiments reducing the rate of CELL DEATH
showed that although the rate of CELL DEATH within CYSTS during
growth is normally quite low, CELL DEATH still contributes to
controlling CELL number and maintaining SLSL CYSTS.I ti s
possible that environmental adjustments may provide conditions
in which MDCK cell cystogenesis produces normal SLSL cysts
without requiring cell death, as occurs in human alveolar type II
epithelial cells [18,19].
Relative to cystogenesis in Matrigel, cells grown in collagen
produce smaller cysts with fewer cells and delayed polarization.
That delay might play a role in formation of smaller cysts.
However, ISMA experiments showed that delaying POLARIZATION
(Figure 8) increased cell number and decreased the percentage of
CYSTS with single LUMENS. We take those observations as strong
evidence that delayed cell polarization alone is insufficient to
account for that difference in cystogenesis within collagen and
Matrigel cultures.
Future in vitro experiments
As illustrated in Figure 9, a goal is to build, expand, and validate
in silico mechanistic networks that map to plausible causal linkages
between intracellular details and features of MDCK cell
phenotype in culture. A prerequisite is to have CELLS capable of
achieving increasingly fine-grained and expanding coverage of
MDCK cell, cluster, and cyst behaviors under different conditions.
Advances in imaging technology have made doing so easier.
Similar coverage will be needed of intracellular (subcellular)
dynamics, including the behaviors of cell components under
different conditions. We anticipate that studies of in vitro MDCK
cell cystogenesis using high-resolution, time-lapse microscopy will
reveal new behavioral details at each level. Recent studies have
employed confocal time-lapse microscopy to understand lumen
formation, but only imaged cells for eight hours [20]. Ewald et al.
[21] set the standard for long-term time-lapse microscopy in their
work on the elongation of mouse mammary ducts, in which they
captured individual images every 15 minutes for five days, using
high-sensitivity cameras to avoid phototoxicity.
There is ample evidence that tension within the extracellular
matrix influences epithelial cell behaviors [22,23]. Paszek et al.
[22] demonstrated that increasing matrix stiffness resulted in
tumorigenic behavior in MCF-10A cells. It seems reasonable to
expect changes in MDCK cell, cluster, and/or cyst behaviors as
Matrigel stiffness, density, and additives are changed. Experiments
similar to those within [22] conducted with MDCK cells and for
longer durations are needed to expand ISMA coverage of MDCK
phenotype in important ways.
Although the underlying in vitro molecular mechanisms to
which the TS and LS ISMA map remain unclear, in vitro
experiments may indicate one mechanism as being more plausible.
Careful analysis of images generated through time-lapse micros-
copy is expected to be informative. If the elapsed time between
individual cyst polarization and stabilization of division rate or
mean cell size are similar between cysts, that would be supportive
of an internal clock mechanism. However, if the interval varied
between cysts, that would falsify such a mechanism. If mean lumen
size when division rate and cell size have stabilized are similar
between cysts, that would support the shift mechanism based on
lumen size. Experiments are suggested in Supporting Text S1 to
begin identifying potential molecular counterparts to TS and LS
ISMA mechanisms.
Future in silico experiments
Five directions for in silico experiments present themselves. The
first two require seeking contradictory or supportive literature
evidence of in silico experiments. 1) Exploring the consequences of
parameter changes will provide insight into ISMA’s mechanism-
phenotype relationships for which there may be biological
counterparts [1]. A full suite of parameter change experiments
was conducted using the LS-ISMA; results are presented in Figure
S11. One example is to explore the consequences of changing
deathRateEpi and deathRateLumen (Figures 7 and S11), including
setting both to 0. Another is to vary lumenGrowthRate to explore the
Figure 9. ISMA-to-in vitro cell culture mappings. Left: MDCK cell
cultures are the referent wet-lab systems. During experiments, cells
draw on genetically controlled operating principles, and cystogenesis is
the result. Influential mechanistic details are reflected in the collected
data. Right: an abstract mechanistic description, a set of targeted
attributes, and specifications paired to those attributes direct analogue
design. Software components are designed, specified, coded, verified,
and assembled guided by that mechanistic description. The product of
the process is a collection of abstract mechanisms rendered in software.
A clear mapping is intended between ISMA CELLS, their axioms and
operating principles, and MDCK CELL and INTRACELLULAR details. Relative
similarity is controlled in part by parameterizations. Importantly, that
mapping can be concretized iteratively. Compilation and source code
execution gives rise to a working ISMA. Its dynamics are intended to
represent abstractly corresponding dynamics (both observed in movies
and believed to occur) within cultures during ten-day experiments. That
mapping can also be concretized iteratively. Measures of CYSTOGENESIS
provide time series data that are intended to be quantitatively similar
(according to prespecified criteria) to corresponding measures of MDCK
cell cystogenesis. Achieving increasingly stringent SMs provides
degrees of validation.
doi:10.1371/journal.pcbi.1002030.g009
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CYSTOGENESIS (see Figure S11). Addition of any of several
compounds to the culture media in vitro will stimulate cyst
expansion. Examples include cholera toxin and forskolin. 2)
Modify axioms and operating principles to simulate targeted
mechanistic interventions. One example (see Results) is to modify
the way in which CELLS calculate their axis of DIVISION. Another is
to modify how MATRIX is represented in order to explore
consequences of altered MATRIX properties on CYSTOGENESIS.
Currently, MATRIX is simply a grid space state. Matrix could be
represented using a CPM ‘‘cell’’ that offers resistance to CELL
advancement. So doing opens the door to exploration of a variety
of MATRIX-CELL interactions that could map to proteins altering
local matrix properties. 3) Systematically expand the targeted
attributes while keeping CELLS atomic. Movies, such as Video S1
from [9] along with the current literature, contain examples of
many behaviors beyond the scope of the current ISMAs. Adding
any one of the following to the list of targeted attributes will falsify
the current ISMAs. At the cell level: when cells undergo mitosis,
they enlarge temporarily and then return to a smaller size; some
cells (and cysts) move around during the early stages of
cystogenesis; some cells migrate toward each other and cluster
together before initiating division; typically, when cells die in
contact with matrix, they are flushed into the luminal space where
they shrink and disappear. At the cyst level: cysts spin. The process
was described in [20] and recently modeled in [24]. Cyst growth
may have an additional later stage characterized by significantly
slowed expansion, rather than continuing to grow steadily as
predicted by the ISMA. The dynamics of lumen merging are more
complex than the merging events that occur during simulations.
Also, lumens change shape and move within cysts during the initial
stages of growth.
4) Increase realism by transforming CELLS from atomic to
composite objects. The axioms used by CELLS are placeholders for
more fine-grained micromechanisms. The latter can be instanti-
ated in future ISMA descendents. Before we can turn our attention
to intracellular processes, we need new ISMAs in which CELLS are
composite (and eventually hierarchical) analogues that can achieve
essentially the same, targeted SMs as the current ISMAs (Figures 2
and 3). Previous reports [14,19,25] explained that an in silico
analogue (such as the current ISMA) that quantitatively mimics
many cell-level phenomena can be used to begin the sequential
process of drilling down and establishing plausible, causal linkages
between phenotype and molecular level details. Using cross-model
validation procedures, the atomic CELL is replaced by a composite
CELL where phenomenal axioms are replaced by concrete
micromechanisms involving interacting objects that map to
subcellular processes and/or components in the referent. 5) Once
we have the preceding composite CELLS, we can expand the list of
targeted attributes to include subcellular and intracellular
behaviors. Alternatively, expanding the list of targeted attributes
can require transforming CELLS from atomic to composite objects.
Examples of subcellular and intracellular behaviors include the
amount and location of polarization proteins, organelle move-
ment, the organization of the mitotic spindle, formation of a pre-
apical patch, location-dependent lipid compartments within the
membrane, etc. During cell polarization (as detailed in [8]), PTEN
moves to the apical membrane, where it converts PIP3 to PIP2,
which binds to Anx2 and assists in the recruitment of Cdc42 to the
apical membrane. The task at this stage, while adhering to a strong
parsimony guideline, is to add new mechanisms and details that
enable validation against the new, targeted attributes, while
retaining all of those mechanisms and behaviors that enabled
validation during earlier cycles of the IR Protocol. So doing will
enable the in silico exploration, falsification, and validation of
increasingly complex in vitro MDCK cell behaviors, which will
ultimately correlate to in vivo phenotypes of developing epithelial
organs.
We hypothesize that the local cause-and-effect relationships
(mechanisms) occurring in ISMAs during execution, and thus their
morphogenic agenda, have in vitro counterparts. Challenging
these alternative hypotheses can be a focus for future in vitro
experiments and ISMA refinements.
Summary
Through careful application of the IR Protocol, analogues of
MDCK cystogenesis in cultures (ISMAs) were developed, falsified,
refined, and validated against novel, multi-attribute quantitative
data. ISMAs were based on software specifications that enabled in
silico behaviors during simulation to achieve degrees of validation:
to be mapped quantitatively to measures of cystogenesis (targeted
attributes). Those specifications also enabled hypothesizing that
ISMA operating principles, axioms, components, events, and
mechanisms have in vitro counterparts. Predictions of substantive
mechanistic changes were verified by independent experiments.
ISMAs were used to explore and test hypotheses about CELL and
CYST dynamics. The above, coupled in vitro and in silico
experiments led to four insights. 1) The axis of CELL DIVISION
significantly affects LUMEN number without changing CELL number
or CYST size. 2) Reducing the amount of LUMINAL CELL DEATH had
limited effect on CYSTOGENESIS. 3) Later stages of cystogenesis,
marked by a decrease in the rate of cell division and cessation of
the decrease in mean cell size, can be explained by the presence of
a new cell state (called stabilized), which differs in a few key
behaviors. 4) The same, multi-attribute phenotype can be a
consequence of two fundamentally different mechanisms that, in
silico, only alter the mechanism of CELL stabilization. By providing
a new way of thinking about cystogenesis, ISMA simulations have




A single cell suspension of MDCK cells was plated in duplicate
on a layer of 100% Matrigel basement membrane (BD
Biosciences) in the presence of 2% Matrigel in the media. Cysts
were allowed to grow for the indicated duration then fixed with
4% paraformaldehyde. The cells were then stained as described in
[11,26]. Briefly, cells were stained with a monoclonal antibody
against gp135/podocalyxn, and a polyclonal antibody against b-
Catenin. F-actin and nuclei were stained with Alexa-labeled
phalloidin and Hoechst 33342 respectively. Each day, 20 cysts
from the duplicate plates were selected at random and imaged
using a Zeiss 510 laser scanning confocal microscope (Carl Zeiss
Inc.). Images were acquired sequentially in four separate channels.
Cell number was determined by counting the nuclei, when
visible, and actin borders when not. Cyst and lumen perimeter
were traced using ImageJ and the size of the cyst and lumen within
each cross section was calculated using the analyze tool. Cellular
area was found by subtracting lumen area from cyst area; mean
cell area was found by dividing cellular area by the number of
cells; and the ratio of cellular area to cyst area was found by
dividing cellular area by cyst area. Standard deviations and
Similarity Measure values (defined in Results) were calculated
using R. The number of lumens in each cyst was found by
counting the discrete spaces within the cyst bordered by gp135/
podocalyxn and actin.
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tively consistent with results from previous studies [6,9,27], as well
as being internally consistent. The goal of conducting the in vitro
experiments was to provide a particular quantitative perspective
on MDCK cystogenesis. We sought an abstract mechanistic
explanation of one set of cytogenic trajectories. Repeated in vitro
experiments using a different batch of cells could result in distinct
cytogenic trajectories, which might not be explained by the current
ISMAs. Understanding and simulating such different trajectories is
outside the scope of this project.
ISMA uses
An early task in any modeling effort is to state near- and long-
term uses; one must then strive to follow a model development
path intended to achieve those uses. When dealing with biology,
having explanatory mechanistic models necessarily precedes
having predictive mechanistic models. This project is an
important, early step in developing explanatory mechanistic
models of cystogenesis. A truly useful explanatory mechanistic
model is one in which we can observe putative cause-effect events
at several layers as they unfold. Given those considerations, we
envisioned six near-term ISMA uses. 1) Instantiate and challenge
hypotheses about mechanisms of cystogenesis by MDCK cells
under different culture conditions. 2) Make it easy to follow
mechanistic processes and trace cause-effect relationships. 3)
Achieve measures of CYSTOGENESIS during ISMA executions of
increasingly autonomous CELLS that are quantitatively similar to
referent measures (i.e., they achieve targeted SMs). 4) Achieve
increasing overlap of an MDCK cell culture’s phenotype by an
ISMA phenotype. 5) For validated ISMAs, explore the conse-
quences of mechanistic interventions on measures of CYSTOGEN-
ESIS. 6) Expose possible gaps in our knowledge of MDCK cell
cystogenesis. Implicit in these uses is the ability of ISMA behaviors
under different conditions to stand as predictions of MDCK cell
and cyst behaviors under comparable conditions.
The preceding are prerequisites for achieving six long-term
ISMA uses. 1) Enable replacing ISMA operating principles with
concrete mechanisms composed of interacting components. So
doing is required to enable hierarchical linkage of molecular level
details with specific phenotypic attributes. 2) Execute in silico
experiments that test the effect on ISMA CYSTOGENESIS of simulated
chemical and genetic interventions that affect CELL behaviors. 3)
Enable continuous refinement of increasingly trustable, complex,
biomimetic mechanisms that stand as plausible explanations for
increasingly large sets of multi-attribute, multi-source wet-lab data.
4) Represent uncertainty at multiple levels, including uncertainty in
mechanistichypotheses; provideplausiblerepresentationsofsources
of variability in referent data and phenomena. 5) Enable
straightforward redeployment and adaptationof ISMA components
to represent other cell types and their behaviors; examples include
MCF-10A and primary mouse breast organoids. 6) Enable concrete
translations between in vitro knowledge and epithelial diseases such
as autosomal dominant polycystic kidney disease and cancer.
In silico methods
Components and mechanisms mapped as closely as possible to
components and mechanisms in the referent system. ISMAs were
composed of CELLS, LUMINAL space, and EXTRACELLULAR MATRIX.
We set parameters such as the rate of CELL DIVISION and the initial
size of CELLS to map to quantities within the in vitro system.
Simulation began with 2-4 CELLS (to mimic the observed number
of initial cells in vitro) on a 2D 1006100 hexagonal grid. CELLS
expanded in size and divided using the CompuCell3D [28]
cellular Potts model architecture and customized code. Each CELL
occupied multiple locations on a hexagonal grid, thus allowing
CELLS to expand, DIVIDE, change shape, and move in a realistic
manner (Rejniak et al. [16] used an alternative method for
enabling cell shape change). We coupled that with features of the
agent-oriented modeling approach used successfully by [14,29-31].
Each cycle, CELLS stepped through the same decision flow
(Figures 10 and S12); they applied the operating principles
described below to change shape, DIVIDE, change state, create
LUMENS, and DIE. Logic design and implementation was con-
strained by the specifications in Table 1. Note that CELLS are
atomic objects: they have no internal parts. All of their
micromechanisms are in the form of axioms. Some axioms add
behavior variability to ISMAs, as noted in Table S2.
Except as noted, simulations ran using the parameter values in
Table 2. A simulated DAY mapped to an in vitro day and consisted
of 48 simulation cycles, equivalent to 30 minutes per cycle.
Drawing on several years of prior experience experimenting on
MDCK cultures, we specified that when SM1 (defined in Results)
.0.5 for nine of ten days, the results can be considered to be
within the range of experimental and biological variability.
Specifically, when SM1 was achieved, simulation results were
taken to be experimentally indistinguishable from values obtained
from an independently repeated in vitro experiment. Empirical
parameter tuning was used to obtain frequencies of SLSL CYSTS
comparable to that observed in vitro. When SM targets were not
achieved, that specific mechanism was falsified. SMs also allowed
for ISMA validation and falsification when new attributes were
added to the target list (discussed below).
Iterative Refinement Protocol
The Iterative Refinement Protocol (IR Protocol), described in
[14,19,25,29], provided the foundation of our methods. Based on
Figure 10. Key features of ISMA logic and decision control
flow. During a simulation cycle, each CELL steps through five logic
modules sequentially to decide which actions to take based on its local
environment and internal state. A LUMEN’S target area is adjusted; LUMENS
can merge with each other. CELLS that are not DYING may begin to do so.
CELLS adjust their area based on their state and the state of neighboring
CELLS; they stabilize if the LUMEN has reached a critical size. CELLS can create
new LUMENS. Under specified conditions they can divide to form new
CELLS. Future versions of ISMA logic may randomize action control in
order to simulate the parallel nature of event occurrence both within
MDCK cultures and within each cell. See Figure S12 for complete details
of the logic within each of the five modules.
doi:10.1371/journal.pcbi.1002030.g010
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an initial group of qualitative attributes to target and simulate (the
first few in Table 1). We implemented a simple ISMA that
reproduced them, thus achieving an initial degree of validation.
We then added new data, expanding the set of targeted attributes.
So doing falsified the simple analogue. That judgment was based
on observation (for qualitative attributes) and values of the
prespecified SMs (for quantitative attributes). The manner in
which the first analogue was falsified informed us how to develop
an improved version that would survive falsification. During
subsequent cycles, we added new data or features from Table 1 to
the targeted set. So doing often resulted in falsification of the then-
current ISMA. On some occasions, it was clear that an
incrementally more fine-grained set of mechanisms and/or
components would be needed to achieve the specified SMs. On
other occasions, we undertook an empirical search of parameter
space in search of new sets of parameter values that would
reestablish validation. When that search failed, new mechanisms,
sometimes more fine-grained, were developed. That iterative
process ended with the attributes in Table 1 and the corresponding
in silico specifications.
The IR Protocol has a number of benefits. Chief among them
is that once an ISMA is validated against targeted data,
additional data can be added and the analogue reengineered
without invalidating existing mechanisms. The new data will
falsify the current ISMA by design, but a successful revision will
survive falsification by both new and existing data. Because in
silico components and mechanisms map to their in vitro
equivalents, it is often the case that only a subset of ISMA
components and/or operating principles must be modified to
mimic both new and original phenomena. Examples include
a d d i n gan e wCELL state and replacing one axiom with two more
specific axioms. Because of the networked nature of all
mechanistic details, each ISMA change requires some retuning
of the parameterizations of several already existing (unmodified)
ISMA features.
The IR Protocol consists of the following steps: first, specify a
list of targeted attributes, which forms the basis for experimental
hypotheses. Devise a specification that maps in silico components
and operating principles to cell culture counterparts. The
operating principles are expected to enable CELLS to exhibit
behavior that is closely analogous to that observed in vitro.
Implement the analogue in code and execute it to deduce
predictions about the in silico and in vitro system. As stated in
[29], analogue execution is a form of deduction, where the
behavior of the analogue follows logically from the premises
embodied by its initial conditions and input data. In some cases,
this deduction will yield obviously invalid results, which falsifies
the current list of operating principles and prompts the
modification of mechanistic hypotheses. Once the analogue
cannot be falsified by data specific to the current list of targeted
attributes, add one or more new, targeted attributes and repeat
the IR Protocol.
The process facilitates mechanism exploration, leading toward
deeper insight into biological counterparts. Undertaking a series of
tightly coupled in silico and in vitro experiments further increases
the confidence that the results of ISMA intervention experiments
can stand as useful predictions of MDCK counterparts. When
there is sufficient ISMA and MDCK cystogenesis similarity,
we hypothesize there is corresponding mechanistic similarity.
Consequently, results of ISMA intervention experiments will stand
as predictions of in vitro phenomena following corresponding in
vitro interventions. Some of those predictions will merit in vitro
follow-up.
Agent-oriented approach
An advantage of using targeted attributes and specifications is
the flexibility of their implementation. We chose to implement the
ISMAs using an agent-oriented approach as explained below and
described in [25], but their key aspects include object-orientation,
component mapping, spatial orientation, relational grounding
and striving for component autonomy. Agent-oriented models are
frequently implemented using object-oriented programming
techniques, which allow the designer to create individual
computational objects corresponding to agents and components
within the specification. Components and mechanisms are
mapped to analogous components and mechanisms within the
referent. So doing makes translating in vitro and in silico
observations back and forth more intuitive and less complex.
Individual agents can serve as analogues for in vitro components.
Agents are quasi-autonomous and they possess their own internal
control flow and execute actions independent of enclosing agents.
Grounding is defined as the units, dimensions, and/or objects to
which a variable or model constituent refers. When grounding is
relational, variables, parameters, and I/O are in units defined by
other model components. When grounding is absolute, variables,
parameters, and I/O are in real-world units like seconds and mg/
ml. One advantage of using an agent-oriented approach with
relational grounding [25] is that fewer assumptions are required to
create or validate the ISMA, and those that are must be clearly
specified.
The ISMA contains five agents:
1. The experiment agent calls the MDCK plug-in agent and the
Potts agent.
2. The MDCK plug-in agent cycles through CELL agents each
simulation cycle.
3. The Potts agent executes the index change step: pseudorandom
index change attempts and energy calculations.
4. The CELL agents change their state and perform other actions.
5. The screenshot agent, called in a separate thread, records a
screen shot at the end of the execution of the simulation
cycle.
The cellular Potts model
ISMAs were developed using the CompuCell3D (CC3D)
architecture [32,33], an implementation of the Glazier-Graner-
Hogeweg [34] or cellular Potts m o d e l( C P M ) .AC P M‘ ‘ c e l l ’ ’i s
not limited to a one-to-one correspondence between objects and
grid locations. The CPM extends cellular automata so that each
grid location contains an index specifying which simulation
object contains that location. A CPM with 100 grid locations
can contain anywhere from 1 to 100 CELLS. This modification
allows simulations to address CELL size, shape change, and CELL-
CELL adhesion. During a simulation cycle, the Potts agent calls a
pseudorandom index change algorithm that randomly selects a
user-specified number of locations and evaluates whether each
will remain indexed to its current CELL or change to be indexed
to another CELL. If the location remains indexed to the current
CELL, the grid remains unchanged. When a location’s index
changes, that location and the ‘‘energy’’ of the system are
updated.
To calculate whether a location changes index from one CELL to
another, DG is calculated; it is the change in ‘‘energy’’ if that
location changes its index to the new CELL. An acceptance function
generates a probability p based on the value of DG, and then
checks if the pseudorandom number r[0,1],p. When r,p, the
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and if not the change is rejected. When accepted, the energy of the
system changes.
For ISMA CELLS, DG ~ Gnew{ Gold:




Each of these terms is calculated through a separate equation,
detailed below.
Surface area and perimeter
The energy calculation for EnergySurface depends on LambdaArea
(lA) and the difference between the target surface area (TA) and
the current surface area (A):
EnergySurface~lA| A { TA ðÞ
2
The larger LambdaArea is the more changes in TA will affect the
overall energy of the system and the faster these changes will be
reconciled. LambdaArea for CELLS is a user-set parameter, while for
LUMEN it is fixed at 20 to represent the large outward force of the
expanding lumen.
The calculation of EnergyPerimeter is similar:
EnergyPerimeter~lP| P { TP ðÞ
2
Adhesion, connectivity, and TIGHT JUNCTIONS
The ‘‘energy’’ of adhesion depends on the CELL type and its
location. For location (i, j), the energy is the sum of values
calculated between (i, j) and all neighboring points residing in
separate CELLS. If, for example, two of the six neighboring points
reside in another CELL, then the energy of adhesion would be
2?X1–2, where X1–2 is a parameter controlling the adhesion energy
between CELLS of type 1 and type 2. Separate adhesion energy
parameters are specified for each pair of CELL types (Table S3).
The ‘‘energy’’ of connectivity is generally 0, but if changing the
CELL index of a location results in a location being isolated from
the rest of the CELL, an energy penalty is assessed by setting
EnergyConnectivity to be very large. As a result, CELLS cannot split
into pieces except when they undergo CELL DIVISION.
In addition to maintaining connectivity between all points in a
CELL, an ISMA maintains integrity between TIGHT JUNCTIONS,
preventing them from being remodeled in the index change step
during a simulation cycle. If the ISMA detects that the change in a
point would result in a TIGHT JUNCTION being remodeled, it assesses
an energy penalty by setting EnergyConnectivityi to be very large. A
detailed explanation of tight junction remodeling is provided in
Text S1.
CompuCell3D and custom code
CC3D is designed from a system-based perspective. Each
simulation cycle, each aspect of the system is executed, from the
index change step that selects random points, to the plug-ins that
update aspects of the system. CC3D was not designed from an
agent-oriented perspective, so it was necessary to expand it to gain
required capabilities. MCell objects were added to CELL objects to
create a bi-directional mapping between individual points and the
CELLS that contained them. These objects and their control flow
were executed in sequence by the MDCK plug-in to grant full
agency to CELLS, which previously only executed after a location
within the CELL boundary changed its index. Every simulation
cycle all points in the grid are surveyed to assess which CELL they
are indexed to and a reference is stored in an MCell object
corresponding to that CELL, as shown in Figure 11. Thereafter that
MCell can be queried to find out what points are located within its
corresponding CELL object.
The version of CompuCell3D used to develop this project has
been superseded (see Text S1) by the current available version.
The capabilities provided by the current version were not judged
necessary for the ISMA, especially due to the significant addition
of custom code. The project was not adapted to the updated
version.
CELLS compute their target size using a value of ideal area
As shown in Results, we observed that prior to cells stabilizing in
vitro, their size correlated with the size of the cyst and its cell
number. We hypothesized that operation of yet-to-be identified
micromechanisms provides each cell with a target size. We
speculated that a cell might use information such as the tension
between it and neighboring cells, lumen pressure, and the ratio of
lumen and matrix contact area in order to update its target size.
To mimic the decrease in mean cell area observed in vitro, we
developed and used an algorithm that is a placeholder for yet-to-
be-designed, concrete micromechanisms that can be implemented
in a future ISMA. Each individual CELL adjusted its size and shape
so that a target area W, the projected wedge area (a wedge that
includes the portion of the perimeter in contact with MATRIX and
terminates at the CYST center), would move toward or equal an
ideal value. The parameter wedgeArea was a value based on the
Figure 11. MCell point assignment flow chart. An MCell point has
no specific cystogenesis counterpart. Once per simulation cycle, each
point is assigned to the MCell agent associated with the CELL enclosing
that point. MCell point lists are initialized during each simulation cycle.
Additionally, surrounding CELLS engulf isolated points.
doi:10.1371/journal.pcbi.1002030.g011
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2 area observed in vitro. An ISMA
calculated W using the following formula:
W~Az
M2A
LzM ðÞ L{M ðÞ
A is the area of the CELL, M is one-half the number in CELL grid
edges in contact with MATRIX, and L is one-half the number in cell
grid edges in contact with LUMEN. This formula assumes that CYSTS
are somewhat circular. Variations in actual CELL size caused by
non-circular CYSTS resulted in variance in CELL area similar to that
observed in vitro. The CELL subtracted W from wedgeArea and set its
target change in area to the resulting value (with a final maximum
value of wedgeArea). Use of this algorithm during early simulation
cycles caused mean CELL area to decrease and CYST area to
increase, mimicking observed in vitro data (Figure 2C).
Once CELLS stabilized, they no longer used the above equation.
Instead, CELLS strove to maintain an area that increased only
slightly as contact with the LUMEN increased. We speculated that
cells within cysts in vitro must maintain a minimal cell height even
as they are stretched by the expanding lumen. We specified that
ISMAs use a similar guideline.
CELLS compute a target perimeter
From in vitro observations, it seems likely that cells have genetic
and environmentally imposed targets for the areas occupied by
different surfaces (cell-cell interfaces, basal, and apical). We
specified that 2D CELLS have a target perimeter value (TP) that
is computed using the CELL’s current area. For simplicity, we
specified that a CELL compute TP using the perimeter P of a circle






K is a scaling factor and multiplier is user-specified. Two CELLS
having identical areas will have identical TP values, so if one has a
larger P the difference between P and TP will also be larger,
causing that CELL to move toward circularity faster.
CELL POLARIZATION and stabilization
The value of polarCounter was set to equal a pseudorandom value
r[polarDelay ? 0.75, polarDelay ? 1.25] when a CELL first contacted
MATRIX. Thereafter, it decreased by one each simulation cycle.
Upon reaching 0, CELL state changed from UNPOLARIZED to
POLARIZED. Consequently, polarCounter is the CELL’S counterpart to a
cell, having established matrix contact, changing and moving
around its components in a process that ends when tight junctions
have formed and the apical surface is isolated and complete.
A correlation was observed between mean cell size and the rate
of cell division in vitro, but a causal link was not apparent.
Individual cells may sense the area of matrix contact in part
through b1-integrin signaling [26]. They may sense the area of
lateral cell-cell contact in part using catenins and cadherins [35].
That information may influence whether a cell divides or not. As
stated in Discussion, tension transduced by the subapical F-actin
network could allow cells to sense the size of the lumen. Such
information supported our decision to use LUMEN size as a signal
for CELL stabilization. Each simulation cycle, a CELL bordering
MATRIX and LUMEN queried the LUMEN for its size. When that value
4 1000 was greater than the parameter stableRatio, the CELL
changed to the stabilized state.
CELL DIVISION
Decrementing cycleCounter is a CELL’s counterpart to moving
through the phases of the cell cycle. CycleCounter is a variable that is
initialized based on cellCycle (a user-specified parameter that
controls the duration of the CELL cycle) and decremented
thereafter. CELLS implemented the following method of CELL
DIVISION. For the first CELL and for daughter CELLS after DIVISION,
the value of cycleCounter was set to a pseudorandom value
r[0.75?cellCycle, 1.25?cellCycle] and then decremented in each CELL
in every simulation cycle in which the CELL had an area .
doublingArea/2. When cycleCounter reached zero, a CELL DIVIDED
(Figure 12), splitting its area in half on an axis, and using the
parameter divisionReg to determine the method of calculating the
axis of DIVISION.
When divisionReg =0 , CELLS chose the axis of DIVISION
randomly. If it was 1, CELLS used oriented DIVISION, finding their
axis of DIVISION as shown in Figure 12. CELLS recorded the location
of their MIDBODY as a point. When DIVIDING, the CELL connected
Figure 12. ISMA CELL DIVISION.C ELL DIVISION depends on the CELL
neighborhood. Single isolated CELLS (top) that have not DIVIDED have no
MIDBODY and DIVIDE with a random axis of DIVISION. When CELLS DIVIDE they
find their centroid and store it as the MIDBODY of their daughter CELLS.
CELLS that have previously DIVIDED and have a MIDBODY utilize it for
subsequent DIVISIONS. For these organized DIVISIONS (top), the axis of DIVISION
is determined by a line drawn from a CELL’s current centroid to the
stored MIDBODY.C ELLS in contact with a LUMEN will also DIVIDE in an
organized fashion (bottom), using a line between their centroid and
that of the LUMEN to determine the axis of DIVISION. When the axis of
DIVISION is determined, all points on one side of the line are assigned to a
new CELL while all points on the other remain assigned to the original
CELL.
doi:10.1371/journal.pcbi.1002030.g012
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points above the line to a new CELL and all points below to the old
CELL. It then set the MIDBODY of the both CELLS to the centroid of
the just-divided CELL. When divisionReg =2 , CELLS divided
randomly until they reached the POLARIZED state and then used
oriented DIVISION. DivisionReg = 3 specified reversed DIVISION,
where CELLS would find the axis of DIVISION as stated above, but
then add 90 degrees, reversing DIVISION orientation.
After a CELL divided, the value of cycleCounter for both daughter
CELLS was reset to a new random value as detailed above. Its value
of polarCounter did not change. The new CELL inherited all values
from the parent CELL, except polarCounter, which was set to
r[0.5?polarDelay, 1.5?polarDelay]–polarDelay + polarCounter(parent).
So doing made the newly created CELL have a polarCounter value
close to but not identical to that of the parent CELL.
CELL clustering and CELL DEATH
In vitro data analysis revealed that when the cultures began
growing, the mean in vitro cell number was about 2 (Table S4),
indicating that a small amount of clustering took place after the
cells were plated. That was expected because in Matrigel culture
suspended cells settle on the layer of 100% Matrigel and thus most
cysts grow in the same plane. Accordingly, simulations began with
a single CELL, but at simulation cycle 1, the cycleCounter of that CELL
was reduced to 1, causing it to DIVIDE during the following
simulation cycle. In addition, since in vitro cells are not always at
the beginning of their cell cycle when plated, the value of
cycleCounter for the two CELLS was changed to equal a pseudoran-
dom number r[(1 – clusterProb)xcellCycle, cellCycle]. So doing
allowed the amount of clustering to be increased without changing
the CELL DIVISION rate, simply by increasing clusterProb.
Cell death is an important factor in MDCK cystogenesis.
However, it is not clear that it is required for cyst formation. In
order to validate that CYSTS did not ignore or excessively rely on
CELL DEATH for normal LUMEN formation, the amount of CELL
DEATH observed in silico was quantified and compared to that
observed in vitro. In vitro analysis of cell death was conducted in
[9]: MDCK cysts were cultured as in this report and fixed and
stained with an antibody for activated caspase-3 (cleaved in
apoptotic cells).
Within the ISMA, a CELL began DYING when a pseudorandom
number r[0, 1] was less than deathRateEpi if the CELL contacted
MATRIX or deathRateLumen if it did not. Once a CELL entered the
DYING state it shrank until its area reached zero. It was then
removed from the simulation. Each DAY, the number of CYSTS with
DYING CELLS was recorded and the percentage calculated (Figure 5).
The data was separated based on whether CELLS were in contact
with the MATRIX or not.
Drawing on literature evidence [36-38] and expert opinion we
estimated the average time between apoptotic bodies first being
visible and a dying cell breaking up into pieces to be roughly five
hours. The value of the parameter dyingShrinkRate specified the
amount that the TA of a DYING CELL was lowered each simulation
cycle (Table 2). Mean DYING time ranged from 6.5 to 13 simulation
cycles, with an overall mean value of 9.2, which maps to 4.6 hours
when one simulation cycle is grounded to 30 minutes.
LUMENS and their creation
POLARIZED CELLS create a new LUMEN when two conditions are
met. 1) The CELL contacts MATRIX, but is not in contact with an
existing LUMEN. 2) The location chosen for LUMEN creation is
adjacent to another POLARIZED CELL also not in contact with an
existing LUMEN. The point chosen for LUMEN creation is the CELL’S
MIDBODY (Figure 12), which was the centroid of the parent CELL
that previously DIVIDED to create the current CELL.
Lumen formation involves cells creating and secreting fluid.
Having CELLS create and release units of LUMEN content could
simulate that. One unit could correspond to a single grid space.
Those units could merge with other units or with an existing
LUMEN object. However, absent validation evidence for the other
ISMA mechanisms, implementing such a fine-grained (somewhat
complicated, multi-parameter) mechanism simply because it seems
biomimetic would have been contrary to the IR Protocol’s strong
parsimony guideline. We took advantage of CC3D capabilities
and elected to use a more abstract, simpler approach. There is no
disadvantage in doing so because a strength of this class of
analogues is that a simple mechanism that achieves a degree of
validation can later be replaced with a more detailed and realistic
counterpart. Using cross-model validation [25], this can be done
without compromising other ISMA mechanisms that have also
achieved degrees of validation [14].
Within ISMAs, LUMENS are a different class of ‘‘CELL’’ object.
Their only action options are to expand and merge. After a LUMEN
is created, it expands using the following axiom.
TA ~lumenGrowthRate | estimatedArea
| totalNeighbors{lgrSubtract
LumenGrowthRate is a user-specified parameter; estimatedArea is
the area of CELLS in contact with the LUMEN added to the LUMEN’s
area; totalNeighbors is the number of CELLS in contact with the
LUMEN;a n dlgrSubtract is a quantity based on a user-specified
parameter and the degree CELLS are stretched. CELLS that are
more stretched have a higher lgrSubtract value, reducing the rate of
LUMEN expansion. A LUMEN does not have a target perimeter
value—its perimeter is determined entirely by the perimeter of
the CELLS surrounding it. LUMENS can merge when their TIGHT
JUNCTIONS are reorganized.
TIGHT JUNCTION maintenance
TIGHT JUNCTIONS (TJs) were implemented in order to simulate
aspects of MDCK lumen expansion. TJS exist where two CELLS
contact each other and a LUMEN. A TJ is two points—one in each
neighboring CELL—adjacent to a point within a LUMEN (see Text
S1 and Figure S13). TJS control LUMEN expansion and merging
and prevent CELLS from contacting multiple LUMENS. At the end of
a simulation cycle, when a TJ is adjacent to a different TJ, the
TJs are reorganized and the index of the two TJ points is
transferred to the neighboring LUMEN. Then the two LUMENS,n o w
in contact with each other, merge together. In addition, TJs can
reorganize to allow LUMEN expansion. To do so, at the end of a
simulation cycle all points within TJs execute the following
algorithm. A TJ point first surveys its neighboring points to verify
they are not in contact with another LUMEN and that they are not
in the MATRIX or within an UNPOLARIZED CELL.I tt h e nd e t e r m i n e s
if any of its neighboring points are in different CELLS but are not
also TJs. To reorganize, the TJ point computes the free energy
change if its index changes to the neighboring LUMEN and then
uses the acceptance function to accept or reject that change. If
the change is accepted, the TJ becomes LUMEN, and the
neighboring point becomes a new TJ.
Scaling observations from 2D to 3D
We recorded aspects of in vitro cyst growth by obtaining
cross-sectional images taken through the center of cysts. These
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Based on the symmetry observed within the cross section, in
addition to separate analysis of 3D structures, we believe that
cysts were roughly symmetrical in 3D. Using this information,
we extrapolated 3D values for total cell number, cyst volume,
and lumen volume from the measured values of cross-sectional
cell number, cyst area, and lumen area. We found that the
trends observed for cell number and mean cell area held when
the system was projected into 3D. If future targeted attributes
required specific modeling in 3D, we could take advantage of
the 3D capabilities of CompuCell3D, addressing considerations
raised in [39].
Data storage
The in silico system recorded data about CELLS and CYSTS into a
MySQL database as specified within Text S1.
Supporting Information
Figure S1 CYSTOGENESIS measures for TS ISMA. Experiments
followed the same experimental design as described in the text.
Measures (red) were taken during CYSTOGENESIS. In vitro data are
provided (blue) for comparison. Designations and symbols are the
same as in Figure 2. TS ISMA used the parameter values in
Table 2, except for stableRatio, which was set to 1000 and shiftDelay,
which was set to 200.
(TIF)
Figure S2 Percent of CYSTS with different numbers of lumens for
TS ISMA. The experiments are the same as in Figure S1.
Designations and symbols are the same as in Figure 3.
(TIF)
Figure S3 Percentage of CYSTS with DYING CELLS when
dyingShrinkRate was reduced. (A) In vitro data reproduced from
[9]. (B) ISMA data from 50 CYSTS over ten DAYS using parameter
settings from Table 2, except for dyingShrinkRate, which was
changed from 9 to 4.5. Blue bars: percentage of cysts observed to
have apoptotic cells without matrix contact. Red bars: percentage
of cysts observed to have apoptotic cells with matrix contact.
(TIF)
Figure S4 CYSTOGENESIS measures when the axis of CELL division
is random. Experiments followed the same design as in Figure S1.
Measures, designations, and symbols are also the same as in Figure
S1. LS ISMAs used the parameter values in Table 2, except for
divisionReg, which was set to 0.
(TIF)
Figure S5 CYSTOGENESIS measures when the axis of CELL
DIVISION is reversed. Experiments followed the same design as in
Figure S1. Measures, designations, and symbols are also the same
as for Figure S1. LS ISMAs used the parameter values in Table 2,
except for divisionReg, which was set to 3.
(TIF)
Figure S6 CYSTOGENESIS measures with no LUMINAL CELL DEATH.
Experiments followed the same design as in Figure S1. Measures,
designations, and symbols are the same as for Figure S1. LS
ISMAs used the parameter values in Table 2, except for
deathRateLumen, which was set to 0.
(TIF)
Figure S7 Percent of CYSTS with different numbers of LUMENS
with no LUMINAL CELL DEATH. The experiments are the same as in
Figure S4. Designations and symbols are the same as in Figure 3.
(TIF)
Figure S8 CYSTOGENESIS measures when CELL POLARIZATION was
delayed. Experiments followed the same design as in Figure S1.
Measures, designations, and symbols are also the same as for
Figure S1. LS ISMAs used the parameter values in Table 2, except
for CELL POLARIZATION, which was delayed as described in the text.
(TIF)
Figure S9 CYSTOGENESIS measures for GM ISMA. Experiments
followed the same design as in Figure S1 except that GM ISMAs
were used. Measures, designations, and symbols are also the same
as for Figure S1. Top: note the large variances after DAY 5.
(TIF)
Figure S10 Percent of CYSTS with different numbers of LUMENS
for GM ISMA. The experiments are the same as in Figure S9.
Designations and symbols are the same as in Figure 3.
(TIF)
Figure S11 Parameter sweeping results. Experiments followed
the same design as in Figures 2 and 3. Designations are the same
as in Figures 2 and 3. Parameters changed from settings in Table 2
are listed within each Figure. S11-1 to S11-5: TS ISMA. S11-6
through S11-80 used the LS ISMA. Except for S11-1 to S11-5, all
parameters were fixed except the single parameter being varied.
S11-6 to S11-9: varied wedgeArea. S11-10 to S11-13: varied
lambdaArea. S11-14 to S11-17: varied stableTargetArea. S11-18 to
S11-23: varied cellCycle. S11-24 to S11-27: varied stableCycleDelay.
S11-28 to S11-31: varied lambdaPerim. S11-32 to S11-35: varied
polarDelay. S11-36 to S11-39: varied shiftDelay with high stableRatio.
S11-40 to S11-44: varied lgrSubtract. S11-45 to S11-48: varied
doublingArea. S11-49 to S11-52: varied multiplier. S11-53 to S11-60:
varied lumenGrowthRate. S11-61 to S11-64: varied deathRateLumen.
S11-65 to S11-68: varied deathRateEpi. S11-69 to S11-72: varied
dyingShrinkRate. S11-73 to S11-76: varied clusterProb. S11-77 to S11-
80: varied stableRatio.
(PDF)
Figure S12 Full ISMA logic and control flow. Shown are the
details of the five components of Figure 10.
(TIF)
Figure S13 TIGHT JUNCTION reorganization. TIGHT JUNCTIONS
(TJs) prevent CELLS from contacting multiple LUMENS.A )T J
counting when a point is within a CELL (left) or LUMEN (right).
B) During the index change step, index changes that result in a
different number of TJs before and after the change will be
rejected. C) When pairs of TJs are adjacent and meet
requirements, LUMENS will merge together. D) TJ reorganization
cannot occur if it will result in a CELL contacting multiple LUMENS.
E) Allowed TJ reorganization results in LUMEN expansion.
(TIF)
Table S1 SM2 values for the ISMA. An SM2 value is the
absolute value of the coefficient of variance (for a specific measure)
subtracted from the in vitro coefficient of variance. Values over
0.25 (black) did not achieve the validation target described in the
text. Values between 0.15 and 0.25 (gray) achieved the moderate
Mechanisms of MDCK Cystogenesis
PLoS Computational Biology | www.ploscompbiol.org 17 April 2011 | Volume 7 | Issue 4 | e1002030validation target. Values less than 0.15 (white) achieved the strong
validation target.
(DOC)
Table S2 Sources of stochasticity within ISMAs. The listed
events or variable assignments provide behavior variability during
CYSTOGENESIS. Note that index changes, which are random,
contribute to many CELL level events, including shape change
and LUMEN expansion.
(DOC)
Table S3 Additional ISMA parameters. Parameters used for the
ISMA system and for the adhesion plug-in are listed along with
descriptions, default values used for simulation, and parameter
ranges that are expected to give normal results.
(DOC)
Table S4 Mean cell number per day for cysts grown in Matrigel.
Numbers in bold italic are measured, mean values and non-bold
numbers are projected values. Projected values were found by
multiplying or dividing the measured mean values by the scaling
factor of 1.56. During the first four days of growth, the number of
cells increased by a constant factor of 1.4 to 1.8 per day, with a
value of 1.56 minimizing the percent error between projected and
measured mean values. Using that scaling factor, the number of
cells at day 0 was estimated to be 2.1, indicating that some
clustering took place within the Matrigel culture. To reflect this
observation, ISMAs implemented CELL clustering.
(DOC)
Text S1 Supporting methods.
(PDF)
Video S1 ISMA time-lapse movie of typical CYST development.
This experiment followed the experimental design described in the
textandused Table2 parametersettings.CELLSbeginto POLARIZE at
0:07, two LUMENS form by 0:11 and merge at 0:15. Sample CELL
DEATH observed between 0:35 and 0:38. CELL stabilization occurs at
0:39. Frame rate: 6 simulation cycles per second.
(MOV)
Video S2 ISMA time-lapse movie of multiple LUMEN formation.
This experiment also followed the experimental design described
in the text and used Table 2 parameter settings. CELL POLARIZA-
TION begins at 0:08 and LUMEN formation occurs at 0:09. (Note
CELLS without LUMEN contact near the top of the CYST from 0:09 to
0:34.) Second and third LUMENS form at 0:35 and 0:36, delaying
stabilization of neighboring CELLS. Most CELLS stabilize at 0:42,
while CELLS not in contact with primary LUMEN stabilize at 0:44.




We thank members of the BioSystems group and the Mostov laboratory
(notably David Bryant) for helpful discussions and suggestions. We thank
Donald Delmar Davis for providing computational support. Finally, we are
grateful for the valuable discussion and feedback provided by Virginia
Platt. The work was abstracted in part from a dissertation to be presented
by JAE to the Graduate Division, University of California, San Francisco,
CA, in partial fulfillment of the Ph.D. degree.
Author Contributions
Conceived and designed the experiments: JAE AD CAH KEM. Performed
the experiments: JAE AD. Analyzed the data: JAE AD CAH. Contributed
reagents/materials/analysis tools: JAE AD CAH KEM. Wrote the paper:
JAE CAH. Performed in vitro experiments: AD. Analyzed results of in
vitro experiments: JAE AD. Engineered the software: JAE. Designed ISMA
experiments: JAE CAH. Executed ISMA experiments: JAE. Analyzed
simulation results of ISMA experiments: JAE CAH KEM AD.
References
1. Kim SH, Debnath J, Mostov K, Park S, Hunt CA (2009) A computational
approach to resolve cell level contributions to early glandular epithelial cancer
progression. BMC Syst Biol 3: 122.
2. Kim SH, Park S, Mostov K, Debnath J, Hunt CA (2009) Computational
investigation of epithelial cell dynamic phenotype in vitro. Theor Biol Med
Model 6: 8.
3. Grant MR, Mostov KE, Tlsty TD, Hunt CA (2006) Simulating properties of in
vitro epithelial cell morphogenesis. PLoS Comput Biol 2: e129.
4. Gin E, Tanaka EM, Brusch L (2010) A model for cyst lumen expansion and size
regulation via fluid secretion. J Theor Biol 264: 1077–1088.
5. Wang AZ, Ojakian GK, Nelson WJ (1990) Steps in the morphogenesis of a
polarized epithelium. I. uncoupling the roles of cell-cell and cell-substratum
contact in establishing plasma membrane polarity in multicellular epithelial
(MDCK) cysts. J Cell Sci 95: 137–151.
6. Zheng Z, Zhu H, Wan Q, Liu J, Xiao Z, et al. (2010) LGN regulates mitotic
spindle orientation during epithelial morphogenesis. J Cell Biol 189: 275–288.
7. O’Brien LE, Zegers MM, Mostov KE (2002) Opinion: Building epithelial
architecture: Insights from three-dimensional culture models. Nat Rev Mol Cell
Biol 3: 531–537.
8. Martı ´n-Belmonte F, Gassama A, Datta A, Yu W, Rescher U, et al. (2007)
PTEN-mediated apical segregation of phosphoinositides controls epithelial
morphogenesis through Cdc42. Cell 128: 383–397.
9. Martı ´n-Belmonte F, Yu W, Rodriguez-Fraticelli AE, Ewald AJ, Werb Z, et al.
(2008) Cell-polarity dynamics controls the mechanism of lumen formation in
epithelial morphogenesis. Curr Biol 18: 507–513.
10. Lam TN, Hunt CA (2009) Discovering plausible mechanistic details of hepatic
drug interactions. Drug Metab Dispos 37: 237–246.
11. O’Brien LE, Jou TS, Pollack AL, Zhang Q, Hansen SH, et al. (2001) Rac1
orientates epithelial apical polarity through effects on basolateral laminin
assembly. Nat Cell Biol 3: 831–838.
12. Campisi J, d’Adda di Fagagna F (2007) Cellular senescence: When bad things
happen to good cells. Nat Rev Mol Cell Biol 8: 729–740.
13. Wang Y, Liang Y, Vanhoutte PM (2010) SIRT1 and AMPK in regulating
mammalian senescence: A critical review and a working model. FEBS Lett. Dec
2. E-pub ahead of print. doi;10.1016/j.febslet.2010.11.047.
14. Tang J, Hunt CA (2010) Identifying the rules of engagement enabling leukocyte
rolling, activation, and adhesion. PLoS Comput Biol 6: e1000681.
15. Rejniak KA, Anderson AR (2008) A computational study of the development of
epithelial acini: I. sufficient conditions for the formation of a hollow structure.
Bull Math Biol 70: 677–712.
16. Rejniak KA, Wang SE, Bryce NS, Chang H, Parvin B, et al. (2010) Linking
changes in epithelial morphogenesis to cancer mutations using computational
modeling. PLoS Comput Biol 6: e1000900.
17. Lin HH, Yang TP, Jiang ST, Yang HY, Tang MJ (1999) Bcl-2 overexpression
prevents apoptosis-induced Madin-Darby canine kidney simple epithelial cyst
formation. Kidney Int 55: 168–178.
18. Yu W, Fang X, Ewald A, Wong K, Hunt CA, et al. (2007) Formation of cysts by
alveolar type II cells in three-dimensional culture reveals a novel mechanism for
epithelial morphogenesis. Mol Biol Cell 18: 1693–1700.
19. Kim SH, Yu W, Mostov K, Matthay MA, Hunt CA (2009) A computational
approach to understand in vitro alveolar morphogenesis. PLoS One 4: e4819.
20. Ferrari A, Veligodskiy A, Berge U, Lucas MS, Kroschewski R (2008) ROCK-
mediated contractility, tight junctions and channels contribute to the conversion
of a preapical patch into apical surface during isochoric lumen initiation. J Cell
Sci 121: 3649–3663.
21. Ewald AJ, Brenot A, Duong M, Chan BS, Werb Z (2008) Collective epithelial
migration and cell rearrangements drive mammary branching morphogenesis.
Dev Cell 14: 570–581.
22. Paszek MJ, Zahir N, Johnson KR, Lakins JN, Rozenberg GI, et al. (2005)
Tensional homeostasis and the malignant phenotype. Cancer Cell 8: 241–254.
23. Wells RG (2008) The role of matrix stiffness in regulating cell behavior.
Hepatology 47: 1394–1400.
24. Marmaras A, Berge U, Ferrari A, Kurtcuoglu V, Poulikakos D, et al. (2010)
A mathematical method for the 3D analysis of rotating deformable
Mechanisms of MDCK Cystogenesis
PLoS Computational Biology | www.ploscompbiol.org 18 April 2011 | Volume 7 | Issue 4 | e1002030systems applied on lumen-forming MDCK cell aggregates. Cytoskeleton 67:
224–240.
25. Hunt CA, Ropella GE, Lam TN, Tang J, Kim SH, et al. (2009) At the biological
modeling and simulation frontier. Pharm Res 26: 2369–2400.
26. Yu W, Datta A, Leroy P, O’Brien LE, Mak G, et al. (2005) b1-integrin orients
epithelial polarity via Rac1 and laminin. Mol Biol Cell 16: 433–445.
27. Kim M, Datta A, Brakeman P, Yu W, Mostov KE (2007) Polarity proteins
PAR6 and aPKC regulate cell death through GSK-3b in 3D epithelial
morphogenesis. J Cell Sci 120: 2309–2317.
28. Cickovski TM, Huang C, Chaturvedi R, Glimm T, Hentschel HG, et al. (2005)
A framework for three-dimensional simulation of morphogenesis. IEEE/ACM
Trans Comput Biol Bioinform 2: 273–288.
29. Engelberg JA, Ropella GE, Hunt CA (2008) Essential operating principles for
tumor spheroid growth. BMC Syst Biol 2: 110.
30. Kim SH, Matthay MA, Mostov K, Hunt CA (2010) Simulation of lung alveolar
epithelial wound healing in vitro. J R Soc Interface 7: 1157–1170.
31. Lam TN, Hunt CA (2010) Mechanistic insight from in silico pharmacokinetic
experiments: Roles of P-glycoprotein, Cyp3A4 enzymes, and microenviron-
ments. J Pharmacol Exp Ther 332: 398–412.
32. Swat MH, Hester SD, Heiland RW, Zaitlen BL, Glazier JA, et al. (2010)
CompuCell3D manual, version 3.4.2. 2010: 123. 123 p.
33. Glazier JA, Balter A, Popławski NJ (2007) Magnetization to morphogenesis:
A brief history of the Glazier-Graner-Hogeweg model. In: Rejniak KA, ed.
Single-Cell-Based Models in Biology and Medicine. Basel: Birkha ¨user. pp
79–106.
34. Graner F, Glazier JA (1992) Simulation of biological cell sorting using a two-
dimensional extended Potts model. Phys Rev Lett 69: 2013–2016.
35. Nathke IS, Hinck L, Swedlow JR, Papkoff J, Nelson WJ (1994) Defining
interactions and distributions of cadherin and catenin complexes in polarized
epithelial cells. J Cell Biol 125: 1341–1352.
36. Collins JA, Schandi CA, Young KK, Vesely J, Willingham MC (1997) Major
DNA fragmentation is a late event in apoptosis. J Histochem Cytochem 45:
923–934.
37. Gavrieli Y, Sherman Y, Ben-Sasson SA (1992) Identification of programmed cell
death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:
493–501.
38. Tyas L, Brophy VA, Pope A, Rivett AJ, Tavare JM (2000) Rapid caspase-3
activation during apoptosis revealed using fluorescence-resonance energy
transfer. EMBO Rep 1: 266–270.
39. Galle J, Hoffman M, Aust G (2009) From single cells to tissue architecture-a
bottom-up approach to modelling the spatio-temporal organisation of complex
multi-cellular systems. J Math Biol 58: 261–283.
Mechanisms of MDCK Cystogenesis
PLoS Computational Biology | www.ploscompbiol.org 19 April 2011 | Volume 7 | Issue 4 | e1002030